Oliwia Koszła

Medical University of Lublin

Poland

Research Interests

Explore related searches

Professors in Poland

Contact this professor

Get a free first email built on one of their papers, ready for you to edit and send yourself.

Articles (13)

Year:

2025

Year:

2025

Year:

2024

Year:

2023

Year:

2022

Year:

2022

Year:

2022

Year:

2022

Year:

2022

Year:

2021

Year:

2021

Year:

2020

Year:

2020

Collaborators (12)

Bartosz Skóra

POLAND

View details

Agata Zięba

Medical University of Lublin

POLAND

View details

Katarzyna Targowska-Duda

Associate Professor

Medical University of Lublin

POLAND

View details

Renata Studzińska

Nicolaus Copernicus University

POLAND

View details

Sylwia Woźniak

Medical University of Lublin

POLAND

View details

Agnieszka Anna Kaczor

associate professor

Medical University of Lublin

POLAND

View details

Antón Leandro Martínez Rodríguez

SPAIN

View details

Lena Majchrowicz

Instytut Biologii Doswiadczalnej im M Nenckiego Polskiej Akademii Nauk

POLAND

View details

Wojciech Plazinski

Medical University of Lublin

POLAND

View details

Anita Plazinska

Associate Professor

Medical University of Lublin

POLAND

View details

Konrad A. Szychowski

POLAND

View details

Dariusz Matosiuk

Head of Department

Medical University

POLAND

View details

ApplyKite TwinLearns as you apply

Make your next move.

Prepare your application

Review drafts before you send them.

Oliwia Koszła

Research Interests

Explore related searches

Contact this professor

Articles (13)

Impact of Hericium erinaceus and Ganoderma lucidum metabolites on AhR activation in neuronal HT-22 cells

New Derivatives of 2-(Cyclohexylamino)thiazol-4(5H)-one as Strong Inhibitors of 11β-Hydroxysteroid Dehydrogenase Type 1: Synthesis, Antiproliferative and Redox-Modulating Activity

Analysis of pharmacokinetic profile and ecotoxicological character of cefepime and its photodegradation products

Synthesis of Novel 2-(Cyclopentylamino)thiazol-4(5H)-one Derivatives with Potential Anticancer, Antioxidant, and 11β-HSD Inhibitory Activities

Multitarget Derivatives of D2AAK1 as Potential Antipsychotics: The Effect of Substitution in the Indole Moiety

In vitro and in vivo evaluation of antioxidant and neuroprotective properties of antipsychotic D2AAK1

Screening and Structure–Activity Relationship of D2AAK1 Derivatives for Potential Application in the Treatment of Neurodegenerative Diseases

Cancer on-target: Selective enhancement of 3-bromopyruvate action by an electromagnetic field in vitro

Allosteric modulation of dopamine D2L receptor in complex with Gi1 and Gi2 proteins: the effect of subtle structural and stereochemical ligand modifications

Current Approaches and Tools Used in Drug Development against Parkinson’s Disease

N-(3-{4-[3-(trifluoromethyl)phenyl]piperazin-1-yl}propyl)-1H-indazole-3-carboxamide (D2AAK3) as a potential antipsychotic: In vitro, in silico and in vivo evaluation of a multi-target ligand

The Antipsychotic D2AAK1 as a Memory Enhancer for Treatment of Mental and Neurodegenerative Diseases

Multi-targeted drug design strategies for the treatment of schizophrenia

Collaborators (12)

Bartosz Skóra

Agata Zięba

Katarzyna Targowska-Duda

Renata Studzińska

Sylwia Woźniak

Agnieszka Anna Kaczor

Antón Leandro Martínez Rodríguez

Lena Majchrowicz

Wojciech Plazinski

Anita Plazinska

Konrad A. Szychowski

Dariusz Matosiuk

Make your next move.